Research Sample bioBank

Product ID: BBS0000-G2900433673110518D1 | Heart Failure | Clinical Research Sample


Product ID Name Origin Matrix Vial (ml) Qty. Avail. Type Price
BBS0000-G2900433673110518D1 Heart Failure Ukraine Serum
1.00 Diagnostic Clinical Samples $200.00
Patient Ethnicity:
Storage Temp:
Test 1:
ECG | Heart
Test Data 1:
Detail 1:
Sinus rhythm regular, heart rate 60 Signs of preinfarction cardiosclerosis of the anterior septum sections from the apex and side wall 09/06/2019
Test 2:
Laboratory results
Test Data 2:
C-reactive protein (CRP) - 1.06 mg/l; Creatine Kinase-MB (CPK-MB) - 14 U/l; Troponin I - <0.1ng/ml; NT-proBNP - 132.6 pg/ml
Detail 2:
Test 3:
HIV I & II | HBV | HCV Results
Test Data 3:
Detail 3:
Blood Type: Unknown
Co-morbidities: Chronic cerebrovascular accident 01/01/2017, Chronic gastroduodenitis 01/01/2010, Coronary artery bypass grafting-3; Mammary coronary bypass-1 01/16/2018
Current Medications: Co-Prenesa (Perindopril, Indapamide) 4/1.25 mg, Carvedilol 12.5 mg, Torasemide 10 mg
Height: 65.75 in
Weight: 180 lbs
Is Pregnant: False
Smoking Notes: Non-Smoker
Symptoms: Pain in the heart, shortness of breath when walking, weakness, dizziness, Cor-tons is weakened, rhythmic as extrasystoles, emphasis II tone on the aorta, heart rate 68, moderate swelling of the legs.
ECG | Heart Systolic function persists. Mitral valve insufficiency, grade II. Hypertrophy of the interventricular septum. 9/6/2019
Treatment of Comorbidities Lira (Citicoline), Neurotropine (Mexidol), Nolpaza (Pantoprazolum)
Diagnosis Ischemic heart disease:Exertional angina, Functional class, grade II-III. Postinfarction cardiosclerosis (2017), Aortocoronary bypass-3; Interventricular septum-1 (1/16/2018). Aortic malformation, stage I-II; Mitral valve insufficiency, stage I-II; Arterial hypertension,grade III, stage II, risk IV. Heart failure, grade IIA. Functional class, grade II (NYHA).

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.